Product description

Rolapitant is used for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

It is in R&D stage.

Read more

Specifications

Categories APIs
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Rolapitant

Contact information

Address

Telephone

Website

View all contact information